Get the Stockscreener App
1.05
0.96%
0.01
After Hours:
1.07
0.02
+1.90%
Estrella Immunopharma Inc stock is traded at $1.05, with a volume of 13,128.
It is up +0.96% in the last 24 hours and up +21.39% over the past month.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
See More
Previous Close:
$1.04
Open:
$1.0668
24h Volume:
13,128
Relative Volume:
0.66
Market Cap:
$38.92M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-3.50
EPS:
-0.3
Net Cash Flow:
$-18.01M
1W Performance:
+0.00%
1M Performance:
+21.39%
6M Performance:
+2.94%
1Y Performance:
-11.02%
1-Day Range:
$1.05
$1.07
1-Week Range:
$0.9901
$1.10
52-Week Range:
$0.63
$1.78
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Name
Estrella Immunopharma Inc
Sector
Industry
Phone
(510) 318-9098
Address
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
1.05 | 38.92M | 0 | -8.82M | -18.01M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Estrella Immunopharma Inc Stock (ESLA) Latest News
Does Estrella Immunopharma Inc. qualify in momentum factor screening2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Applying big data sentiment scoring on Estrella Immunopharma Inc.Earnings Performance Report & Free Community Supported Trade Ideas - Newser
Is Estrella Immunopharma Inc. showing signs of accumulationQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser
Published on: 2025-09-12 13:55:04 - Newser
Real time breakdown of Estrella Immunopharma Inc. stock performanceMarket Risk Summary & Weekly High Potential Stock Alerts - Newser
Is Estrella Immunopharma Inc. meeting your algorithmic filter criteria2025 Sector Review & Safe Capital Preservation Plans - Newser
Statistical indicators supporting Estrella Immunopharma Inc.’s strengthTrade Exit Summary & Proven Capital Preservation Tips - Newser
How to forecast Estrella Immunopharma Inc. trends using time seriesMarket Volume Report & High Win Rate Trade Tips - Newser
Price action breakdown for Estrella Immunopharma Inc.Quarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
Volume spikes in Estrella Immunopharma Inc. stock – what they meanJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - Newser
Is it time to cut losses on Estrella Immunopharma Inc.2025 Investor Takeaways & Stock Portfolio Risk Management - Newser
How to read the order book for Estrella Immunopharma Inc.2025 Trading Volume Trends & Daily Growth Stock Investment Tips - Newser
What’s next for Estrella Immunopharma Inc. stock priceJuly 2025 Breakouts & Verified Entry Point Signals - Newser
Heatmap analysis for Estrella Immunopharma Inc. and competitorsJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - Newser
Estrella Immunopharma Inc. stock trend outlook and recovery pathWeekly Market Outlook & Target Return Focused Stock Picks - Newser
Earnings visualization tools for Estrella Immunopharma Inc.New Guidance & Verified Trade Idea Suggestions - Newser
Top chart patterns to watch in Estrella Immunopharma Inc.Market Trend Review & High Conviction Buy Zone Alerts - Newser
What to expect from Estrella Immunopharma Inc. in the next 30 daysGold Moves & Expert Approved Trade Ideas - Newser
Custom watchlist performance reports with Estrella Immunopharma Inc.Insider Buying & Weekly Market Pulse Alerts - Newser
How moving averages guide Estrella Immunopharma Inc. tradingWeekly Trading Summary & Expert Verified Movement Alerts - Newser
Estrella Immunopharma Inc. stock trend forecastWeekly Profit Analysis & Daily Chart Pattern Signal Reports - Newser
Can technical indicators confirm Estrella Immunopharma Inc.’s reversalJuly 2025 Trends & Momentum Based Trading Ideas - Newser
What momentum shifts mean for Estrella Immunopharma Inc.July 2025 Rallies & Low Drawdown Investment Strategies - Newser
Risk vs reward if holding onto Estrella Immunopharma Inc.Share Buyback & Real-Time Volume Spike Alerts - Newser
Is Estrella Immunopharma Inc. trending in predictive chart modelsQuarterly Market Review & AI Enhanced Execution Alerts - Newser
Market reaction to Estrella Immunopharma Inc.’s recent newsEarnings Beat & Intraday High Probability Alerts - Newser
What MACD signals say about Estrella Immunopharma Inc.Weekly Gains Report & Smart Swing Trading Techniques - Newser
Has Estrella Immunopharma Inc. found a price floorRate Cut & Reliable Breakout Forecasts - Newser
Will breakout in Estrella Immunopharma Inc. lead to full recoveryOil Prices & Free Technical Confirmation Trade Alerts - Newser
Can Estrella Immunopharma Inc. stock outperform in a bear marketNew Guidance & Technical Pattern Based Buy Signals - Lancaster City Council
What’s the recovery path for long term holders of Estrella Immunopharma Inc.Quarterly Performance Summary & Risk Adjusted Swing Trade Ideas - Newser
Using Ichimoku Cloud for Estrella Immunopharma Inc. technicalsTrade Signal Summary & Verified Stock Trade Ideas - Newser
Estrella Immunopharma Inc Stock (ESLA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):